Editorial: Immunotherapy for NSCLC with oncogenic driver variants

Yijia Du, Qian Chu, Yanyan Lou, Yong He, Hongbo Hu, Qipeng Hu, Meijuan Huang

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Article number1095947
JournalFrontiers in Oncology
StatePublished - Dec 8 2022


  • immune checkpoint inhibitors
  • lung cancer
  • oncogenic driver variants
  • targeted therapy resistance
  • tumor immune microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this